A Koneksa Digest:  Examining Apple Watch

As the use of wearables in clinical research grows, the Apple Watch is increasingly being evaluated for use in drug development trials. Its combination of capabilities and qualities - including look and feel that can improve patient compliance; worldwide accessibility to ease the logistics of global trials; and the ability to continuously collect rich data in convenient, real-world settings - enable innovative clinical research. Additionally, as pilots and adoption increase, the burden of evidence in the literature grows.  Learn more: 


  • The shift toward more decentralized clinical trials.
  • The benefits Apple Watch can offer those trials, now and in the future.
  • The validation of Apple Watch for this use - both how, and why.

Download the Digest

AppleDigest Thumb2

This digest discusses opportunities for Apple Watch implementation in clinical trials to collect physiological data in the real-world environment and capture disease features meaningful to patients, intervention effects, and study subjects’ quality of life. This digest also highlights several recent studies deploying Apple Watch and their results.